---
title: "ASCENDIA PHARMACEUTICALS, INC. SEC filings"
url: https://altstreet.investments/edgar/1855888
kind: edgar-entity
publisher: AltStreet (https://altstreet.investments)
license: Public factual pages may be read, quoted and cited with attribution and a link. Bulk redistribution is not permitted.
---

# ASCENDIA PHARMACEUTICALS, INC.: SEC filings and what they report

| Field | Value |
| --- | --- |
| Entity | ASCENDIA PHARMACEUTICALS, INC. |
| CIK | 1855888 |
| Filing family | Form D |
| Total offering amount (as filed) | $4,084,536 |
| Total sold (as reported) | $4,084,536 |
| Investors (as reported) | 3 |

## Filings (6 on record, newest first)

| Date | Form | Family | SEC link |
| --- | --- | --- | --- |
| November 6, 2026 | D/A | Form D | https://www.sec.gov/Archives/edgar/data/1855888/000185588826000008/ |
| July 24, 2026 | D | Form D | https://www.sec.gov/Archives/edgar/data/1855888/000185588826000005/ |
| June 4, 2025 | D | Form D | https://www.sec.gov/Archives/edgar/data/1855888/000185588825000001/ |
| October 11, 2024 | D | Form D | https://www.sec.gov/Archives/edgar/data/1855888/000185588824000001/ |
| July 13, 2022 | D | Form D | https://www.sec.gov/Archives/edgar/data/1855888/000185588822000002/ |
| April 20, 2021 | D | Form D | https://www.sec.gov/Archives/edgar/data/1855888/000185588821000001/ |


## More

- Entity page (HTML, with events, parties and the platform record): https://altstreet.investments/edgar/1855888
- SEC EDGAR filing index: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001855888&owner=include&count=40
- Signal history, evidence passages and the entity graph are AltStreet Terminal features: https://altstreet.investments/terminal

---

Source page: https://altstreet.investments/edgar/1855888
Machine index: https://altstreet.investments/llms.txt
AltStreet reads what platforms, funds and issuers file with the SEC and what they tell investors, and publishes the difference. Figures are as filed or as captured on the date stated; nothing here is investment advice.
